China Wants Vaccination to Start With a Doctor's Prescription
Three departments have issued guidance to roll out vaccine prescriptions across hospitals and grassroots clinics during the next five-year plan.
Three departments have issued guidance to roll out vaccine prescriptions across hospitals and grassroots clinics during the next five-year plan.
A national drug inspection notice named 17 manufacturers and 27 batches, including a paediatric product from the Tongrentang house.
The 2026 catalogue adds 107 drugs, 51 of them first-class innovative medicines, and takes effect on January 1, 2027.
Chinese doctors and platforms are pushing back against AI-generated 'blue alien' videos spreading medical pseudoscience in family group chats.
Central funding of 14 billion yuan is building 100,000 nursing beds and 30,000 childcare slots as planners target household burdens.
UpTCR predicts which T-cell receptors bind cancer antigens, slashing months of lab screening and narrowing 100,000 melanoma variants to a handful.
A Zhejiang University circuit published in Nature exploits ribosomal mistakes common in tumors, shrinking colorectal and pancreatic cancers in mice.
U.S. regulators refused to approve ivonescimab, developed by China's Akeso, saying the potential Keytruda rival did not prove patients lived longer.
Health officials warned surrogacy agreements carry no legal protection and underground clinics endanger women and newborns.
China added 107 drugs, a record 51 of them innovative, to its 2026 medical insurance catalog, easing costs for cancer and rare-disease patients.